Terms ending in 2028
Every in-force patent on Shire LLC's record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,425,937 | Pharmaceutical Compositions for Glucocorticoid Replacement Therapy In force · High confidence | Shire Viropharma LLC | In force | High confidence | |
| US 7,772,222 | Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,463,222 | Methods for Treatment of Complications of Prematurity Comprising Administration of Igf-I and IGFBP-3 In force · Low confidence | Shire Human Genetic Therapies, Inc. | In force | Low confidence | |
| US 9,782,347 | Topical Corticosteroids for the Treatment of Inflammatory Diseases of the Gastrointestinal Tract In force · High confidence | Viropharma Biologics LLC | In force | High confidence | |
| US 11,357,859 | Compositions for the Treatment of Gastrointestinal Inflammation In force · Medium confidence | Viropharma Biologics LLC | In force | Medium confidence | |
| US 10,293,052 | Compositions for the Treatment of Gastrointestinal Inflammation In force · High confidence | Viropharma Biologics LLC | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Shire LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.